Search research articles
Contact Us
Filters
Showing results (1-10 of 20) with videos related to
Page
of 2
Sort By:
Methods (San Diego, Calif.)
|
August 25, 2004
Automated systems for protein crystallization
Joel Bard, Kimberly Ercolani, Kristine Svenson, et al.
Scientific Reports
|
May 24, 2022
Crystal structure of ultra-humanized anti-pTau Fab reveals how germline substitutions humanize CDRs without loss of binding'
Alette R Brinth, Kristine Svenson, Lidia Mosyak, et al.
Scientific Reports
|
August 17, 2023
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
Pragya Rampuria, Lidia Mosyak, Adam R Root, et al.
The Journal of Biological Chemistry
|
April 26, 2013
Engineering a monomeric Fc domain modality by N-glycosylation for the half-life extension of biotherapeutics
Tetsuya Ishino, Mengmeng Wang, Lidia Mosyak, et al.
The Journal of Biological Chemistry
|
May 2, 2013
Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis
Oleg V Kovalenko, Andrea Olland, Nicole Piché-Nicholas, et al.
Journal of Molecular Biology
|
July 6, 2013
Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC
Alexey Gribenko, Lidia Mosyak, Sharmistha Ghosh, et al.
Journal of Medicinal Chemistry
|
May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site
Ariamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria
Youjun Yang, Anatoly Severin, Rajiv Chopra, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
Andrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes
Zhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 20) with videos related to
Sort By:
Page
of 2
Methods (San Diego, Calif.)
|
August 25, 2004
Automated systems for protein crystallization
Joel Bard, Kimberly Ercolani, Kristine Svenson, et al.
Scientific Reports
|
May 24, 2022
Crystal structure of ultra-humanized anti-pTau Fab reveals how germline substitutions humanize CDRs without loss of binding'
Alette R Brinth, Kristine Svenson, Lidia Mosyak, et al.
Scientific Reports
|
August 17, 2023
Molecular insights into recognition of GUCY2C by T-cell engaging bispecific antibody anti-GUCY2CxCD3
Pragya Rampuria, Lidia Mosyak, Adam R Root, et al.
The Journal of Biological Chemistry
|
April 26, 2013
Engineering a monomeric Fc domain modality by N-glycosylation for the half-life extension of biotherapeutics
Tetsuya Ishino, Mengmeng Wang, Lidia Mosyak, et al.
The Journal of Biological Chemistry
|
May 2, 2013
Atypical antigen recognition mode of a shark immunoglobulin new antigen receptor (IgNAR) variable domain characterized by humanization and structural analysis
Oleg V Kovalenko, Andrea Olland, Nicole Piché-Nicholas, et al.
Journal of Molecular Biology
|
July 6, 2013
Three-dimensional structure and biophysical characterization of Staphylococcus aureus cell surface antigen-manganese transporter MntC
Alexey Gribenko, Lidia Mosyak, Sharmistha Ghosh, et al.
Journal of Medicinal Chemistry
|
May 26, 2006
Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site
Ariamala Gopalsamy, Rajiv Chopra, Kitae Lim, et al.
Antimicrobial Agents and Chemotherapy
|
January 27, 2006
3,5-dioxopyrazolidines, novel inhibitors of UDP-N- acetylenolpyruvylglucosamine reductase (MurB) with activity against gram-positive bacteria
Youjun Yang, Anatoly Severin, Rajiv Chopra, et al.
Journal of Medicinal Chemistry
|
August 5, 2005
Synthesis and structure-activity relationship of novel 6-aryl-1,4-dihydrobenzo[d][1,3]oxazine-2-thiones as progesterone receptor modulators leading to the potent and selective nonsteroidal progesterone receptor agonist tanaproget
Andrew Fensome, Reinhold Bender, Rajiv Chopra, et al.
ACS Medicinal Chemistry Letters
|
June 6, 2014
Discovery of HSD-621 as a Potential Agent for the Treatment of Type 2 Diabetes
Zhao-Kui Wan, Eva Chenail, Huan-Qiu Li, et al.
Page
of 2